K&A Acts on Major Healthcare M&A Transaction

K&A advised Dallah Healthcare Company and other sellers on the signing of the sale of the entire stake in Dr. Mohammed bin Rashid Al Fagih & Partners Company (MRFP) for SAR 1.6 billion in cash, one of the largest M&A transactions in the Kingdom's healthcare sector and among the largest M&A deals announced this year.

‍

MRFP owns and operates Dr. Mohammed AlFagih Hospital in Riyadh, a multi-specialty hospital with a capacity of approximately 350 beds. K&A advised on all aspects of the transaction, including deal structuring, negotiations, transaction documentation, and related capital markets matters. The deal remains subject to the satisfaction of conditions precedent including regulatory approvals.

‍

The K&A team was led by Partner Basma Khashoggi and Counsel Ghaida Meaigel, supported by Associate Rana Azhar and the team of associates based out of Saudi Arabia. The transaction involved complex multi-stakeholder negotiations and a significant regulatory dimension reflecting the scale and strategic profile of the target.

‍

This transaction builds on K&A's track record advising Dallah Healthcare, including on its acquisition of Care Shield Holding Company (Kingdom Hospital) and its earlier share swap transaction with Ayyan Investment Company. It further reinforces K&A's position as the leading adviser on high-profile healthcare M&A in Saudi Arabia and follows the firm's continued recognition as a Tier 1 / Band 1 firm for Corporate/M&A by IFLR1000, Chambers, and Legal 500.

‍